Clover U.S. IND Clearance and Initiation of Study for RSV Vaccine Candidate

 -- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform --

-- Evaluation of SCB-1019 as part of a respiratory combination Trimer-Tagged PreF vaccine (RSV + hMPV ± PIV3) is also on track for clinical trial initiation in 2025 --

https://www.prnewswire.com/news-releases/clover-announces-us-ind-clearance-and-initiation-of-revaccination-clinical-study-for-rsv-vaccine-candidate-scb-1019-302408671.html